Influence of ACE (I/D) and G460W polymorphism of α-adducin in autosomal dominant polycystic kidney disease

Nephrology Dialysis Transplantation

Volumn 18, Issue 10, 2003, Pages 2032-2038

  Persu, Alexandre ^a   El Khattabi, Ouarda ^a   Messiaen, Thierry ^b   Pirson, Yves ^a   Chauveau, Dominique ^c   Devuyst, Olivier ^a  

^a UNIVERSITY OF LOUVAIN MEDICAL SCHOOL   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Adducin; ADPKD; Angiotensin converting enzyme; Modifier gene; Polymorphisms

Indexed keywords

ADDUCIN; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGE; AGED; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; GENDER; GENOTYPE; HUMAN; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; PEDIGREE; PRIORITY JOURNAL; SAMPLE SIZE; SURVIVAL;

AGE DISTRIBUTION; AGE OF ONSET; CALMODULIN-BINDING PROTEINS; CELL ADHESION MOLECULES, NEURON-GLIA; COHORT STUDIES; CONFIDENCE INTERVALS; DISEASE PROGRESSION; FEMALE; FRANCE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; POLYMORPHISM, GENETIC; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SURVIVAL ANALYSIS;

EID: 0141618433     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg292     Document Type: Article

References (25)

1. Pirson Y, Chauveau D, Grünfeld JP. Autosomal dominant polycystic kidney disease, In: Cameron JS, Davison AM, Grünfeld JP, Kerr DNS, Ritz E, eds. Oxford Textbook of Clinical Nephrology. Oxford University Press, Oxford, UK; 1998: 2393-2415
2. Harris PC. Molecular basis of polycystic kidney disease: PKD1, PKD2 and PKHD1. Curr Opin Nephrol Hypertens 2002; 11: 309-314
3. Peters DJM, Breuning MH. Autosomal dominant polycystic kidney disease: modification of disease progression. Lancet 2001; 358: 1439-1444
4. Rossetti S, Burton S, Strmecki L et al. The position of the polycystic kidney disease 1 (PKD1) gene mutation correlates with the severity of renal disease. J Am Soc Nephrol 2002; 13: 1230-1237
5. Persu A, Devuyst O. Transepithelial chloride secretion and cystogenesis in amosomal dominant polycystic kidney disease. Nephrol Dial Transplant 2000; 15: 747-750
6. Persu A, Stoenoiu MS, Messiaen T et al. Modifier effect of ENOS in autosomal dominant polycystic kidney disease. Hum Mol Genet 2002; 11: 229-241
7. Schunkert H. Polymorphism of the angiotensin-converting enzyme gene and cardiovascular disease. J Mol Med 1997; 75: 867-875
8. Chapman AB, Johnson A, Gabow PA, Schrier RW. The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease. N Engl J Med 1990; 323: 1091-1096
9. Baboolal K, Ravine D, Daniels J et al. Association of the angiotensin I converting enzyme gene deletion polymorphism with early onset of ESRF in PKD1 adult polycystic kidney disease. Kidney Int 1997; 52: 607-613
10. Perez-Oller L, Torra R, Badenas C et al. Influence of the ACE gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease. Am J Kidney Dis 1999; 34: 273-278
11. Konoshita T, Miyagi K, Onoe T et al. Effect of ACE gene polymorphism on age at renal death in polycystic kidney disease in Japan. Am J Kidney Dis 2001; 37: 113-118
12. Uemasu J, Nakaoka A, Kawasaki H et al. Association between angiotensin converting enzyme gene polymorphism and clinical features in autosomal dominant polycystic kidney disease. Life Sci 1997; 60: 2139-2144
13. Lee KB, Kim UK, Lee CC. Association of the ACE gene polymorphism with the progression of autosomal dominant polycystic kidney disease. J Korean Med Sci 2000; 15: 431-435
14. Saggar-Malik AK, Afzal AR, Swissman JS et al. Lack of association of ACE/angiotensinogen genotype with renal function in autosomal dominant polycystic kidney disease. Genet Test 2000; 4: 299-303
15. Schiavello T, Burke V, Bogdanova N et al. Angiotensin-converting enzyme activity and the ACE Alu polymorphism in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 2001; 16: 2323-2327
16. van Dijk MA, Breuning MH, Peters DJ, Chang PC. The ACE insertion/deletion polymorphism has no influence on progression of renal function loss in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 2000; 15: 836-839
17. Fischer M, Baessler A, Schunkert H. Renin angiotensin system and gender differences in the cardiovascular system. Cardiovasc Res 2002; 53: 672-677
18. Ferrandi M, Bianchi G. Genetic mechanisms underlying the regulation of urinary sodium excretion and arterial blood pressure: the role of adducin. Acta Physiol Scand. 2000; 168: 187-193
19. Barlassina C, Schork NJ, Manunta P et al. Synergistic effect of alpha-adducin and ACE genes causes blood pressure changes with body sodium and volume expansion. Kidney Int 2000; 57: 1083-1090
20. Wang JG, Staessen JA, Tizzoni L, Brand E. Renal function in relation to three candidate genes. Am J Kidney Dis 2001; 38: 1158-1168
21. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. John Wiley and Sons, New York, NY; 1980
22. Staessen JA, Ginocchio G, Wang JG et al. Genetic variability in the renin-angiotensin system: prevalence of alleles and genotypes. J Cardiovasc Risk 1997; 4: 401-422
23. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996; 273: 1516-1517
24. Nicod J, Frey BM, Frey FJ, Ferrari P. Role of the alpha-adducin genotype on renal disease progression. Kidney Int 2002; 61: 1270-1275
25. King BF, Reed JE, Bergstralh EJ et al. Quantification and longitudinal trends of kidney, renal cyst, and renal parenchyma volumes in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 2000; 11: 1505-1511